在接受内牙科治疗的患者中使用德克萨米他的治疗管理:一项随机临床试验
Heilyn Joanna Nils1, Cristina Arce Recatalá2, Cosimo Galletti3,4
1Department of Stomatology and Surgery, Faculty of Medicine, University of Salamanca, 37008, Salamanca, Spain. hjnils@outlook.com.
Odontology
|December 19, 2025
概括
与布洛芬相比,手术前的德克萨米他在根管治疗后显著改善了手术后的疼痛缓解. 这一发现表明,德克萨米他可以整合到预防性内牙疼痛管理协议中.
科学领域:
- 牙周内科医院 牙周内科医院 牙周内科医院
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 最佳的术后止痛对于内牙成功至关重要,特别是在炎症时.
- 像德克萨米他这样的葡萄皮质类药物具有抗炎性质,但在内牙科中缺乏广泛的验证.
- 预防性疼痛控制策略在牙科手术中越来越重要.
研究的目的:
- 为了比较手术前的德克萨米他与术后的伊布罗芬在治疗内牙疼痛方面的疗效.
- 评估德克萨米他对根管治疗后早期术后疼痛的影响.
- 评估在内牙患者中预防性德克萨米他的安全性和耐受性.
主要方法:
- 一个随机的,受控的第四期临床试验,涉及82名接受一次性根管治疗的患者.
- 患者接受了手术前4毫克口服德克萨梅他或治疗后400毫克布洛芬.
- 术后疼痛使用视觉模拟尺度 (VAS) 在多个时间点测量,长达24小时.
主要成果:
- 德克萨米他组在干预后6至24小时内显示出明显较低的VAS得分 (p < 0.001).
- 在德克萨米他组中没有报告任何不良事件或需要救援止痛.
- 在疼痛感知方面没有观察到基于性别的显著差异.
结论:
- 一次4毫克的手术前口服剂量提供优越的早期术后止痛,相比于标准的布洛芬方案在根管治疗.
- 这些发现支持预防性德克萨米他在内牙治疗方案中的潜在整合.
- 在广泛的临床采用之前,建议进行进一步的多中心验证.
相关概念视频
01:29Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175
01:26COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K